Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis

References

• Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet. 2016;388(10041):276–284.
   PubMed Web of Science ®Google Scholar
• Li PK, Ng JK, Mcintyre CW. Inflammation and peritoneal dialysis. Semin Nephrol. 2017;37(1):54–65.
   PubMed Web of Science ®Google Scholar
• Zhang W, He J, Zhang F, et al. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol. 2013;26(2):243–253.
   PubMed Web of Science ®Google Scholar
• Lee KH, Cho JH, Kwon O, et al. Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis. Kidney Res Clin Pract. 2016;35(3):169–175.
   PubMed Web of Science ®Google Scholar
• Oh TK, Song IA, Lee JH. Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: a retrospective analysis. Sci Rep. 2018;8(1):14977.
   PubMedGoogle Scholar
• Llop-Talaveron J, Badia-Tahull MB, Leiva-Badosa E. An inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition. Clin Nutr. 2018;37(5):1575–1583.
   PubMed Web of Science ®Google Scholar
• Kim MH, Ahn JY, Song JE, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10(7):e0132109.
   PubMed Web of Science ®Google Scholar
• Moon JS, Ahn SS, Park YB, et al. C-Reactive protein to serum albumin ratio is an independent predictor of all-cause mortality in patients with ANCA-associated vasculitis. Yonsei Med J. 2018;59(7):865–871.
   PubMed Web of Science ®Google Scholar
• Karabağ Y, Çağdaş M, Rencuzogullari I, et al. The C-reactive protein to albumin ratio predicts acute kidney injury in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Lung Circ. 2019;28(11):1638–1645.
   PubMed Web of Science ®Google Scholar
• Ni XF, Wu J, Ji M, et al. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer. Asia Pac J Clin Oncol. 2018;14(6):402–409.
   PubMed Web of Science ®Google Scholar
• General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81:14–18.
   PubMedGoogle Scholar
• Wheeler DC, London GM, Parfrey PS, et al. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. J Am Heart Assoc. 2014;3(6):e001363
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–1911.
   PubMed Web of Science ®Google Scholar
• Cafka M, Rroji M, Seferi S, et al. Inflammation, left ventricular hypertrophy, and mortality in end-stage renal disease. Iran J Kidney Dis. 2016;10(4):217–223.
   PubMed Web of Science ®Google Scholar
• Chen T, Hassan HC, Qian P, et al. High-sensitivity troponin T and C-reactive protein have different prognostic values in hemo- and peritoneal dialysis populations: a cohort study. J Am Heart Assoc. 2018;7:e007876.
   PubMed Web of Science ®Google Scholar
• Farrugia A. Albumin usage in clinical medicine: tradition or therapeutic? Transfus Med Rev. 2010;24(1):53–63.
   PubMed Web of Science ®Google Scholar
• Kim SB, Yang WS, Park JS. Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients. Perit Dial Int. 1999;19(2_suppl):144–149.
   Google Scholar
• Yu D, Cai Y, Chen Y, et al. Development and validation of risk prediction models for cardiovascular mortality in Chinese people initialising peritoneal dialysis: a cohort study. Sci Rep. 2018;8(1):1966.
   PubMedGoogle Scholar
• Huang R, Liu Y, Wu H, et al. Lower plasma visceral protein concentrations are independently associated with higher mortality in patients on peritoneal dialysis. Br J Nutr. 2015;113(4):627–633.
   PubMed Web of Science ®Google Scholar
• Chiu PF, Tsai CC, Wu CL, et al. Trajectories of serum albumin predict survival of peritoneal dialysis patients: a 15-year follow-up study. Medicine (Baltimore). 2016;95(12):e3202.
   PubMed Web of Science ®Google Scholar
• Malgorzewicz S, Chmielewski M, Kaczkan M, et al. Nutritional predictors of mortality in prevalent peritoneal dialysis patients. Acta Biochim Pol. 2016;63(1):111–115.
   PubMed Web of Science ®Google Scholar
• Hassan K, Fadi H. Is hypoalbuminemia a prognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients? Ther Clin Risk Manag. 2014;10:787–795.
   PubMed Web of Science ®Google Scholar
• Oh J, Kim SH, Park KN, et al. High-sensitivity C-reactive protein/albumin ratio as a predictor of in-hospital mortality in older adults admitted to the emergency department. Clin Exp Emerg Med. 2017;4(1):19–24.
   PubMed Web of Science ®Google Scholar
• Xie Q, Zhou Y, Xu Z, et al. The ratio of CRP to prealbumin levels predict mortality in patients with hospital-acquired acute kidney injury. BMC Nephrol. 2011;12(1):30.
   PubMedGoogle Scholar
• Ranzani OT, Zampieri FG, Forte DN, et al. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013;8(3):e59321.
   PubMed Web of Science ®Google Scholar
• Kaplan M, Ates I, Akpinar MY, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hbpd Int. 2017;16(4):424–430.
   Google Scholar
• Mao M, Wei X, Sheng H, et al. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol Lett. 2017;14:7417–7424.
   PubMed Web of Science ®Google Scholar
• Wu M, Guo J, Guo L, et al. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Tumor Biol. 2016;37(9):12525–12533.
   PubMedGoogle Scholar